Scarica l'app Stockscreener
202.29
2.60%
-5.9442
Precedente Chiudi:
$208.23
Aprire:
$206.12
Volume 24 ore:
63,692
Relative Volume:
0.04
Capitalizzazione di mercato:
$33.78B
Reddito:
$16.63B
Utile/perdita netta:
$1.39B
Rapporto P/E:
25.07
EPS:
8.0674
Flusso di cassa netto:
$2.12B
1 W Prestazione:
-0.19%
1M Prestazione:
+10.41%
6M Prestazione:
-16.60%
1 anno Prestazione:
+23.31%
Intervallo 1D:
$202.23
$207.56
Intervallo di 1 settimana:
$201.98
$211.10
Portata 52W:
$154.50
$247.04
Iqvia Holdings Inc Stock (IQV) Company Profile
Nome
Iqvia Holdings Inc
Settore
Industria
Telefono
919-998-2000
Indirizzo
2400 ELLIS ROAD, DURHAM, NC
Compare IQV vs TMO, DHR, IDXX, NTRA, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IQV
Iqvia Holdings Inc
|
202.42 | 34.75B | 16.63B | 1.39B | 2.12B | 8.0674 |
TMO
Thermo Fisher Scientific Inc
|
508.07 | 191.99B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
190.78 | 137.44B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
553.65 | 44.98B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
276.01 | 40.28B | 2.50B | -226.32M | 71.51M | -1.6412 |
A
Agilent Technologies Inc
|
128.41 | 37.04B | 7.23B | 1.41B | 1.09B | 4.979 |
Iqvia Holdings Inc Stock (IQV) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-09 | Aggiornamento | TD Cowen | Hold → Buy |
| 2026-03-06 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2026-03-03 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-12-02 | Ripresa | Morgan Stanley | Overweight |
| 2025-11-13 | Iniziato | BMO Capital Markets | Outperform |
| 2025-11-03 | Downgrade | TD Cowen | Buy → Hold |
| 2025-10-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2025-10-09 | Aggiornamento | HSBC Securities | Hold → Buy |
| 2025-09-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-04-25 | Downgrade | HSBC Securities | Buy → Hold |
| 2025-04-10 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-02-03 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-12-20 | Iniziato | Stephens | Overweight |
| 2024-10-14 | Iniziato | Redburn Atlantic | Buy |
| 2024-09-04 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-07-24 | Downgrade | Jefferies | Buy → Hold |
| 2024-06-06 | Iniziato | Goldman | Buy |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-02-15 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-02-13 | Iniziato | BTIG Research | Buy |
| 2023-11-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-09-06 | Iniziato | HSBC Securities | Buy |
| 2023-03-17 | Iniziato | Truist | Buy |
| 2022-12-06 | Iniziato | Cowen | Outperform |
| 2022-11-17 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-07-15 | Iniziato | SVB Leerink | Outperform |
| 2022-05-24 | Iniziato | Guggenheim | Buy |
| 2022-04-29 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2022-04-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-04-16 | Aggiornamento | Stephens | Equal-Weight → Overweight |
| 2021-03-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Iniziato | Barclays | Overweight |
| 2020-07-07 | Iniziato | Stephens | Equal-Weight |
| 2020-03-02 | Iniziato | Deutsche Bank | Buy |
| 2020-01-08 | Iniziato | Wells Fargo | Overweight |
| 2020-01-07 | Iniziato | Citigroup | Buy |
| 2019-12-13 | Aggiornamento | CFRA | Sell → Hold |
| 2019-11-14 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2019-06-21 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-05-28 | Iniziato | SVB Leerink | Outperform |
| 2019-01-18 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-10-09 | Iniziato | UBS | Buy |
| 2018-10-02 | Reiterato | Robert W. Baird | Outperform |
| 2018-07-25 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2018-07-25 | Reiterato | Stifel | Buy |
| 2018-07-03 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2018-04-13 | Aggiornamento | Goldman | Neutral → Buy |
| 2018-03-07 | Aggiornamento | SunTrust | Hold → Buy |
| 2018-01-19 | Iniziato | Evercore ISI | Outperform |
Mostra tutto
Iqvia Holdings Inc Borsa (IQV) Ultime notizie
Is IQVIA Holdings (IQV) Resilient to AI Concerns? - Yahoo Finance
IQVIA stock holds its line as investors await a fresh catalyst. - AD HOC NEWS
Evercore ISI Adjusts Price Target on IQVIA Holdings Inc to $225 From $195 - Moomoo
Argus Adjusts Price Target on IQVIA Holdings to $235 From $215 - marketscreener.com
HSBC Adjusts Price Target on IQVIA Holdings Inc to $240 From $210 - Moomoo
IQVIA stock steadies on a thin catalyst day. - AD HOC NEWS
IQVIA stock holds focus on its data and services model. - AD HOC NEWS
IQVIA board authorizes additional $2 billion stock buyback - Investing.com
IQVIQVIA Holdings Inc Volatility & Greeks - Finviz
The IQVIA CORE – IQVIA Holdings leans on real-world data backbone - AD HOC NEWS
MidCap Value Fund I's IQVIA Holdings Inc(IQV) Holding History - GuruFocus
IQVIA Holdings Inc outlook and operations as a healthcare data leader - AD HOC NEWS
Here's Why Investors Should Hold IQV Stock in Their Portfolios Now - TradingView
IQVIA Holdings' Q2 2026 Earnings: What to Expect - Barchart.com
IQVIA Holdings (IQV) Is Up 11.1% After Raising Earnings Outlook And Highlighting AI Research Role - Sahm
IQVIA Holdings Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Hardman Johnston Large Cap Equity Holds Firm on IQVIA Holdings (IQV). Here’s Why - Yahoo Finance
IQVIA Holdings Inc (IQV) Stock Up 5.2% and Still Undervalued -- GF Score: 90/100 - GuruFocus
IQVIA Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Is IQVIA (IQV) Stock Soaring Today - Yahoo Finance
IQVIA Holdings highlights its data-driven healthcare platform. Investors focus on long-term growth p - AD HOC NEWS
Baird Adjusts Price Target on IQVIA Holdings Inc to $249 From $230, Maintains Outperform Rating - marketscreener.com
Baird Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $249 - Moomoo
The IQVIA MedTech Acceleratordata-driven support for smaller device makers - AD HOC NEWS
Are Wall Street analysts predicting IQVIA Holdings stock will climb or sink? - MSN
IQVIA Holdings Inc. stock rises Monday, still underperforms market - MarketWatch
Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating - Moomoo
IQVIA Holdings updates AI-powered analytics push, shares on NYSE radar - AD HOC NEWS
IQVIA Life Sciences Hub from IQVIA Holdingsunified data backbone for pharma teams - AD HOC NEWS
The Orchestrated Patient Recruitment from IQVIA Holdings Inc.data-driven outreach for tough trial - AD HOC NEWS
IQVIA Holdings Inc Actuals & Estimates (NYSE:IQV) - TradingView
IQVIA Holdings EPS outlook lifted, shares anchored in S&P 500 healthcare tech - Ad-hoc-news.de
(IQV) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Charles River upgraded, IQVIA downgraded as Morgan Stanley revisits CRO coverage - MSN
IQVIA Holdings consensus stays constructive, shares trade near record territory - Ad-hoc-news.de
IQV Forecast — Price Target — Prediction for 2027 - TradingView
QTS Forecast — Price Target — Prediction for 2027 - TradingView
IQVIA Holdings chart picture stays robust, shares above key 200-day mark - Ad-hoc-news.de
Is IQVIA (IQV) Balancing Slower Revenue Momentum With Its Latest Debt Refinancing Move? - Sahm
IQVIA Holdings Inc (IQV) Shares Surge 8.4% -- What GF Score of 8 - GuruFocus
IQVIA Holdings Jumps 7.4% Amid Sector-Wide Rally - AlphaStreet
Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210 - Moomoo
IQVIA - Forbes
Pharmacovigilance Automation Market Size to Reach USD 5.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
OCE from IQVIA Holdings Inc.cloud CRM that speaks pharma’s language - Ad-hoc-news.de
Does Slower Growth at IQVIA Holdings (IQV) Challenge Its Core Data‑Driven Pharma Enablement Story? - Yahoo Finance
IQVIA Holdings Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
IQVIA Holdings trades in a tight range, technicals flag cautious signal for the shares - AD HOC NEWS
IQVIA Holdings Inc (IQV) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IQVIA Holdings analyst views shift, shares trade below recent targets - Ad-hoc-news.de
IQVIA Holdings, Inc. (IQV): Investor Outlook On A 34% Potential Upside - DirectorsTalk Interviews
Iqvia Holdings Inc Azioni (IQV) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):